{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:46Z","timestamp":1791967846194,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["26ama221141"],"award-info":[{"award-number":["26ama221141"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19790312"],"award-info":[{"award-number":["19790312"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21790412"],"award-info":[{"award-number":["21790412"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24700965"],"award-info":[{"award-number":["24700965"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22114002"],"award-info":[{"award-number":["22114002"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22114001"],"award-info":[{"award-number":["22114001"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K14984"],"award-info":[{"award-number":["17K14984"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["12J04126"],"award-info":[{"award-number":["12J04126"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H06373"],"award-info":[{"award-number":["16H06373"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07117"],"award-info":[{"award-number":["21K07117"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25250016"],"award-info":[{"award-number":["25250016"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K16734"],"award-info":[{"award-number":["19K16734"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22240085"],"award-info":[{"award-number":["22240085"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K18399"],"award-info":[{"award-number":["15K18399"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["07J03878"],"award-info":[{"award-number":["07J03878"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10211"],"award-info":[{"award-number":["25K10211"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009665","name":"Vehicle Games Public Utility Foundation Memorial Foundation","doi-asserted-by":"publisher","award":["#6580"],"award-info":[{"award-number":["#6580"]}],"id":[{"id":"10.13039\/100009665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154598","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:36:51Z","timestamp":1789627011000},"page":"154598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential tyrosine phosphorylation status of the nuclear scaffold Parafibromin\/CDC73 determines its role in cancer development"],"prefix":"10.1016","volume":"837","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-9522","authenticated-orcid":false,"given":"Atsushi","family":"Takahashi-Kanemitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4946-4511","authenticated-orcid":false,"given":"Ippei","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-5328","authenticated-orcid":false,"given":"Naoko","family":"Murata-Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-2649","authenticated-orcid":false,"given":"Masanori","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154598_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154598_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12015-013-9486-8","article-title":"Wnt signaling and the control of human stem cell fate","volume":"10","author":"Van Camp","year":"2014","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.bbrc.2026.154598_bib3","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1038\/sj.onc.1210251","article-title":"Helicobacter pylori CagA interacts with E-cadherin and deregulates the \u03b2-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells","volume":"26","author":"Murata-Kamiya","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.23190","article-title":"Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence","volume":"122","author":"Kurashima","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154598_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","article-title":"Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis","volume":"17","author":"Takahashi-Kanemitsu","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2026.154598_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.20892\/j.issn.2095-3941.2016.0032","article-title":"Developmental pathways associated with cancer metastasis: notch, Wnt, and Hedgehog","volume":"14","author":"Nwabo Kamdje","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154598_bib7","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/cancers7040880","article-title":"Targeting the Hedgehog pathway in pediatric medulloblastoma","volume":"7","author":"Huang","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154598_bib8","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1200\/JCO.2007.15.2264","article-title":"Medulloblastoma stem cells","volume":"26","author":"Fan","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154598_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.154598_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbrc.2026.154598_bib11","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1038\/sj.onc.1210582","article-title":"Human RNA polymerase II-associated factor complex: dysregulation in cancer","volume":"26","author":"Chaudhary","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib12","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","article-title":"Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin","volume":"24","author":"Hahn","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097994","article-title":"Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization","volume":"9","author":"Masi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154598_bib14","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"581","author":"Hahn","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2026.154598_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin--functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154598_bib16","article-title":"The roles of the tumor suppressor parafibromin in cancer","volume":"10","author":"Zheng","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154598_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","article-title":"Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154598_bib18","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1038\/onc.2017.43","article-title":"Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome","volume":"36","author":"Walls","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","article-title":"The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154598_bib20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","article-title":"Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression","volume":"24","author":"Woodard","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2006.08.169","article-title":"Parafibromin inhibits cancer cell growth and causes G1 phase arrest","volume":"350","author":"Zhang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib22","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/sj.onc.1210131","article-title":"Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene","volume":"26","author":"Zhao","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","article-title":"SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver","volume":"43","author":"Takahashi","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2023.07.051","article-title":"Coevolution of the ileum with Brk\/Ptk6 family kinases confers robustness to ileal homeostasis","volume":"676","author":"Kikuchi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gde.2006.12.011","article-title":"The role of Shp2 (PTPN11) in cancer","volume":"17","author":"Mohi","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrc.2026.154598_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mod.2009.02.002","article-title":"The role of Parafibromin\/Hyrax as a nuclear Gli\/Ci-interacting protein in Hedgehog target gene control","volume":"126","author":"Mosimann","year":"2009","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbrc.2026.154598_bib29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/sj.embor.7401045","article-title":"Paf1 complex homologues are required for Notch-regulated transcription during somite segmentation","volume":"8","author":"Akanuma","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2026.154598_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.devcel.2013.08.013","article-title":"YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function","volume":"26","author":"Tsutsumi","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.isci.2018.01.003","article-title":"Transcriptional Co-activator functions of YAP and TAZ are inversely regulated by tyrosine phosphorylation status of parafibromin","volume":"1","author":"Tang","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2026.154598_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","volume":"15","author":"Moroishi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154598_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbagrm.2010.01.001","article-title":"The Paf1 complex: platform or player in RNA polymerase II transcription?","volume":"1799","author":"Jaehning","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.154598_bib35","first-page":"66","article-title":"Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK","volume":"1806","author":"Brauer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.154598_bib36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.devcel.2019.04.018","article-title":"High-Molecular-Weight Hyaluronan is a Hippo pathway ligand directing cell density-dependent growth inhibition via PAR1b","volume":"49","author":"Ooki","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.gene.2012.08.025","article-title":"Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene","volume":"509","author":"Gaffney","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2026.154598_bib38","doi-asserted-by":"crossref","first-page":"13965","DOI":"10.1074\/jbc.RA120.013820","article-title":"Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1","volume":"295","author":"Ben","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154598_bib39","article-title":"The YAP1 isoform, YAP1-2\u03b1, promotes oncogenic properties by inducing liquid-liquid phase separation through specific heterodimerization with TAZ","author":"Ooki","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2026.154598_bib40","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/s41467-019-13665-6","article-title":"PSPC1-interchanged interactions with PTK6 and \u03b2-catenin synergize oncogenic subcellular translocations and tumor progression","volume":"10","author":"Lang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib41","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1038\/sj.onc.1211019","article-title":"Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors","volume":"27","author":"Miyamoto","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154598_bib42","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bbrc.2015.12.117","article-title":"Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling","volume":"469","author":"Noda","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib43","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/jcm11071773","article-title":"Parafibromin is highly expressed in hepatocellular carcinoma and its expression correlates with poor prognosis","volume":"11","author":"Kim","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.154598_bib44","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.28919","article-title":"Shp2 promotes liver cancer stem cell expansion by augmenting \u03b2-catenin signaling and predicts chemotherapeutic response of patients","volume":"65","author":"Xiang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.154598_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13046-019-1417-3","article-title":"MEIS2C and MEIS2D promote tumor progression via Wnt\/\u03b2-catenin and hippo\/YAP signaling in hepatocellular carcinoma","volume":"38","author":"Guan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154598_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ccr.2011.03.023","article-title":"Ptpn11\/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis","volume":"19","author":"Bard-Chapeau","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154598_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00428-007-0572-7","article-title":"Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas","volume":"452","author":"Zheng","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbrc.2026.154598_bib48","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JCMA.0000000000000957","article-title":"POFUT1 promotes gastric cancer progression through Notch\/Wnt dual signaling pathways dependent on the parafibromin-NICD1-\u03b2-catenin complex","volume":"86","author":"Dong","year":"2023","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.bbrc.2026.154598_bib49","doi-asserted-by":"crossref","first-page":"15964","DOI":"10.1074\/jbc.M117.800102","article-title":"O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates notch trafficking","volume":"292","author":"Takeuchi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154598_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.stemcr.2019.03.010","article-title":"The PAF1c subunit CDC73 is required for mouse hematopoietic stem cell maintenance but displays leukemia-specific gene regulation","volume":"12","author":"Saha","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154598_bib51","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1182\/blood-2013-02-486977","article-title":"MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction","volume":"122","author":"Muntean","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154598_bib52","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-021-04013-y","article-title":"PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154598_bib53","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI127374","article-title":"Degradation of splicing factor SRSF3 contributes to progressive liver disease","volume":"129","author":"Kumar","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154598_bib54","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.7150\/ijbs.83368","article-title":"Oncogenic SRSF3 in health and diseases","volume":"19","author":"Jia","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.154598_bib55","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/cancers13123026","article-title":"MAPK\/ERK signaling pathway in hepatocellular carcinoma","volume":"13","author":"Moon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154598_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s43556-025-00327-x","article-title":"WNT signaling in cancer: molecular mechanisms and potential therapies","volume":"6","author":"Liang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbrc.2026.154598_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.154598_bib58","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"de La Coste","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2026.154598_bib59","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41573-025-01234-0","article-title":"Targeting the Hippo pathway in cancer","volume":"24","author":"Harvey","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154598_bib60","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154598_bib61","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154598_bib62","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401895RR","article-title":"Pharmacological regulators of Hippo pathway: advances and challenges of drug development","volume":"39","author":"Lao","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2026.154598_bib63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12032-025-02868-1","article-title":"Wnt signal pathways: new mechanistic approaches and clinical horizons in cancer therapy","volume":"42","author":"Hassan","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2026.154598_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154598_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103729","article-title":"A phase I dose-escalation study of LRP5\/6 antagonist BI 905677 in patients with advanced solid tumors","volume":"9","author":"Lenz","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbrc.2026.154598_bib66","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2767-9764.CRC-25-0502","article-title":"A first-in-human dose-escalation phase I study of basroparib, a tankyrase inhibitor, in patients with advanced-stage solid tumors","volume":"5","author":"Lieu","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154598_bib67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpendmet0292","article-title":"Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation","volume":"2","author":"Dreijerink","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:19:25Z","timestamp":1791965965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26013641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S0006291X26013641"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154598","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential tyrosine phosphorylation status of the nuclear scaffold Parafibromin\/CDC73 determines its role in cancer development","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154598"}}